Boulder Stock Analysis

BIF -  USA Stock  

USD 14.87  0.08  0.54%

The modest gains experienced by current holders of Boulder Growthome could raise concerns from shareholders as the firm it trading at a share price of 14.87 on very low momentum in volume. The company executives have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 0.73. The very small Stock volatility is a good signal to shareholders with longer-term investment horizons.
Continue to Trending Equities.

Boulder Stock Analysis 

 
Refresh
The Boulder Growthome stock analysis report makes it easy to digest most publicly released information about Boulder Growthome and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Boulder Stock analysis module also helps to analyze the Boulder Growthome price relationship with some important fundamental indicators such as market cap and management efficiency.

Boulder Stock Analysis Notes

About 47.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Boulder Growthome next dividend is scheduled to be issued on the 21st of January 2022. Boulder Growth Income Fund, Inc. is a closed-ended balanced mutual fund launched and managed by Boulder Investment Advisers, L.L.C. Boulder Growth Income Fund, Inc. was formed on December 7, 1972 and is domiciled in the United States. Boulder Growthome is traded on New York Stock Exchange in the United States. For more info on Boulder Growthome please contact the company at 785-823-3097 or go to https://www.boulderfunds.net/bif-fundobjective.php.

Boulder Growthome Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Boulder Growthome's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Boulder Growthome or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company has 222.88 M in debt with debt to equity (D/E) ratio of 0.14, which may show that the company is not taking advantage of profits from borrowing. Boulder Growthome has a current ratio of 0.47, suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
Boulder Growthome has about 330.77 K in cash with (140.09 M) of positive cash flow from operations.
Roughly 47.0% of Boulder Growthome shares are held by company insiders

Boulder Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 1.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boulder Growthome's market, we take the total number of its shares issued and multiply it by Boulder Growthome's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has Return on Asset of 0.29 % which means that on every $100 spent on asset, it made $0.29 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 34.33 %, implying that it generated $34.33 on every 100 dollars invested. Boulder Growthome management efficiency ratios could be used to measure how well boulder growthome manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of January 2022, Boulder Growthome shows the Risk Adjusted Performance of 0.2108, downside deviation of 0.647, and Mean Deviation of 0.6233. Boulder Growthome technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Boulder Growthome, which can be compared to its rivals. Please confirm Boulder Growthome treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Boulder Growthome is priced correctly, providing market reflects its regular price of 14.87 per share. Given that Boulder Growthome has jensen alpha of 0.1434, we suggest you to validate Boulder Growthome's prevailing market performance to make sure the company can sustain itself at a future point.

Boulder Growthome Price Movement Analysis

The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Boulder Growthome middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Boulder Growthome. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Boulder Growthome Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boulder Growthome insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boulder Growthome's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boulder Growthome insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Joel Looney over a month ago via Macroaxis 
Purchase by Joel Looney of 480 shares of Boulder Growthome
Joel Looney over three months ago via Macroaxis 
Purchase by Joel Looney of tradable shares of Boulder Growthome
Stephen Miller over six months ago via Macroaxis 
Sale by Stephen Miller of 25862 shares of Boulder Growthome
Joel Looney over a year ago via Macroaxis 
Purchase by Joel Looney of 657 shares of Boulder Growth
Guardian Life Insurance Co Of America over a year ago via Macroaxis 
Boulder Growth exotic insider transaction detected
Sun Life Assurance Co Of Canada over a year ago via Macroaxis 
Boulder Growth exotic insider transaction detected
Massachusetts Mutual Life Insurance Co over a year ago via Macroaxis 
Boulder Growth exotic insider transaction detected
Stewart R Horejsi Trust No 2 over a year ago via Macroaxis 
Sale by Stewart R Horejsi Trust No 2 of 2411987 shares of Boulder Growth
Courtney M Ciciora Trust over a year ago via Macroaxis 
Purchase by Courtney M Ciciora Trust of 223419 shares of Boulder Growth
Courtney M Ciciora Trust over a year ago via Macroaxis 
Purchase by Courtney M Ciciora Trust of 223419 shares of Boulder Growth
Ernest Horejsi Trust No 1b over a year ago via Macroaxis 
Sale by Ernest Horejsi Trust No 1b of 4000 shares of Boulder Growth
Ernest Horejsi Trust No 1b over a year ago via Macroaxis 
Sale by Ernest Horejsi Trust No 1b of 2000 shares of Boulder Growth

Boulder Growthome Technical and Predictive Indicators

Boulder Growthome Forecast Models

Boulder Growthome time-series forecasting models is one of many Boulder Growthome's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boulder Growthome's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Boulder Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Boulder Growthome stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boulder shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Boulder Growthome. By using and applying Boulder Stock analysis, traders can create a robust methodology for identifying Boulder entry and exit points for their positions.
Boulder Growth Income Fund, Inc. is a closed-ended balanced mutual fund launched and managed by Boulder Investment Advisers, L.L.C. Boulder Growth Income Fund, Inc. was formed on December 7, 1972 and is domiciled in the United States. Boulder Growthome is traded on New York Stock Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Boulder Growthome to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module
Continue to Trending Equities. Note that the Boulder Growthome information on this page should be used as a complementary analysis to other Boulder Growthome's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Boulder Stock analysis

When running Boulder Growthome price analysis, check to measure Boulder Growthome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boulder Growthome is operating at the current time. Most of Boulder Growthome's value examination focuses on studying past and present price action to predict the probability of Boulder Growthome's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Boulder Growthome's price. Additionally, you may evaluate how the addition of Boulder Growthome to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Boulder Growthome's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boulder Growthome. If investors know Boulder will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boulder Growthome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Boulder Growthome is measured differently than its book value, which is the value of Boulder that is recorded on the company's balance sheet. Investors also form their own opinion of Boulder Growthome's value that differs from its market value or its book value, called intrinsic value, which is Boulder Growthome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boulder Growthome's market value can be influenced by many factors that don't directly affect Boulder Growthome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boulder Growthome's value and its price as these two are different measures arrived at by different means. Investors typically determine Boulder Growthome value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boulder Growthome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.